ACROBiosystems社 How many targets for bispecific antibody development do you know?
How many targets for bispecific antibody development do you know? |
|||
Hot Targets | |||
CD3 proteins | |||
Features:
> MALS verified heterodimer > High bioactivity and batch-to-batch consistency > Bioactivity verified by clinical bispecific antibody > Various tags and species >>> Learn more about CD3 protein |
|||
PD-1/PD-L1 Proteins | |||
Features:
> High purity and homogeneity > High bioactivity verified > Various tags and species >>> Learn more about immune checkpoint targets |
|||
CD47 Proteins | |||
Features:
> High purity and homogeneity > High bioactivity verified > Suitable for immunization and inhibitor >>> Learn more about CD47 proteins |
|||
Full length CD20 Proteins | |||
Features:
> Authentic conformation > Super bioactivity verified > Exclusive Nanodisc technology >>> Learn more about CD20 proteins |
|||
More bispecific antibody targets | |||
Bioactivity analysis of bispecific antibody | |||
According to Bispecific Antibody Development Programs Guidance for Industry (FDA, 2019), quality attributes may affect pharmacology and should be studied.
With a strong team of scientists, ACROBiosystems also provides high-quality integrated SPR&BLI analytical services. ACROBiosystems has served and collaborated with more than 200 customers from academia and industry. Our work supported multiple antibody drugs IND applications.
|
Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。